Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.

Our results demonstrate that reduced CB2R activity is associated with increased seizure susceptibility. CB2Rs might therefore provide a therapeutic target for the treatment of some forms of epilepsy.